I agree. But there is no market for Viradx. Smart companies who...

I agree. But there is no market for Viradx. Smart companies who actually sell a Covid/Flu test are pulling back:

1. Abbott anticipated the drop and pulled back manufacturing of its PANBIO Cov/Flu. They cited a drop in related testing (worldwide) from $3.3 Billion in US Q1 2022 all the way down to $700 Million last Quarter. But they're smart and announced they are moving toward climate change related virus testing and other initiatives. Their diagnostic sales are down 20%, but if you exclude Covid/Flu testing, they are actually UP.
2. Thermo announced it stopped producing it's Point of Care Rapid PCR based Covid Flu tests and is running out it's inventory.